JP2023529612A5 - - Google Patents
Info
- Publication number
- JP2023529612A5 JP2023529612A5 JP2022574167A JP2022574167A JP2023529612A5 JP 2023529612 A5 JP2023529612 A5 JP 2023529612A5 JP 2022574167 A JP2022574167 A JP 2022574167A JP 2022574167 A JP2022574167 A JP 2022574167A JP 2023529612 A5 JP2023529612 A5 JP 2023529612A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- use according
- formula
- carbon atoms
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2025730A NL2025730B1 (en) | 2020-06-02 | 2020-06-02 | Compounds for treatment of sepsis |
| NL2025730 | 2020-06-02 | ||
| PCT/NL2021/050351 WO2021246868A1 (en) | 2020-06-02 | 2021-06-02 | Chromanol, quinone or hydroquinone compounds for treatment of sepsis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529612A JP2023529612A (ja) | 2023-07-11 |
| JP2023529612A5 true JP2023529612A5 (https=) | 2024-05-27 |
Family
ID=72659292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574167A Pending JP2023529612A (ja) | 2020-06-02 | 2021-06-02 | 敗血症の治療のためのクロマノール、キノン又はヒドロキノン化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230202997A1 (https=) |
| EP (1) | EP4157261A1 (https=) |
| JP (1) | JP2023529612A (https=) |
| AU (1) | AU2021284148A1 (https=) |
| CA (1) | CA3185054A1 (https=) |
| NL (1) | NL2025730B1 (https=) |
| WO (1) | WO2021246868A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2010010C2 (en) * | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6231894B1 (en) * | 1999-10-21 | 2001-05-15 | Duke University | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
| WO2004045534A2 (en) * | 2002-11-15 | 2004-06-03 | Galileo Pharmaceuticals, Inc. | Chroman derivatives for the reduction of inflammation symptoms |
| KR102137450B1 (ko) | 2012-07-12 | 2020-07-27 | 콘드리온 아이피 비.브이. | 미토콘드리아 질환을 치료하기 위한 크로마닐 유도체 |
| NL2010010C2 (en) | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
| MX388654B (es) * | 2015-05-22 | 2025-03-20 | Sulfateq Bv | Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón. |
| US10815211B2 (en) | 2015-10-08 | 2020-10-27 | Khondrion Ip B.V. | Compounds for treating mitochondrial disease |
| AU2017281744B2 (en) | 2016-06-24 | 2022-10-27 | Fundación Para La Investigación Biomédica Del Hospital Gregorio Marañón | Cilastatin for use in the treatment of sepsis |
| SG11202003743SA (en) * | 2017-11-22 | 2020-06-29 | Khondrion Ip B V | Compounds as mpges-1 inhibitors |
| FI3762018T3 (fi) | 2018-03-08 | 2024-04-22 | Am Pharma Bv | Rekombinantti alkalinen fosfataasi käytettäväksi sepsikseen liittyvän akuutin munuaisvaurion hoitamiseen |
-
2020
- 2020-06-02 NL NL2025730A patent/NL2025730B1/en active
-
2021
- 2021-06-02 EP EP21730995.4A patent/EP4157261A1/en active Pending
- 2021-06-02 US US17/928,645 patent/US20230202997A1/en active Pending
- 2021-06-02 WO PCT/NL2021/050351 patent/WO2021246868A1/en not_active Ceased
- 2021-06-02 AU AU2021284148A patent/AU2021284148A1/en active Pending
- 2021-06-02 CA CA3185054A patent/CA3185054A1/en active Pending
- 2021-06-02 JP JP2022574167A patent/JP2023529612A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2418792C2 (ru) | Азольные соединения с нейтротерапевтической активностью | |
| RU2397171C2 (ru) | 9-замещенное производное 8-оксоаденина и лекарственное средство | |
| JP2020125355A (ja) | 併用療法 | |
| RU97115713A (ru) | Соединения, содержащие бензопиран и способ их применения | |
| RU2014131014A (ru) | Димерные соединения-агонисты рецептора fgf (fgfr), способ их получения и их терапевтическое применение | |
| KR970701698A (ko) | 프로스타글란딘 i₂작용물질로서의 나프탈렌 유도체(naphthalene derivatives as prostaglandin i₂agonists) | |
| JP2005526836A5 (https=) | ||
| JP2004533450A5 (https=) | ||
| CA2633057A1 (fr) | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique | |
| CA2683634A1 (en) | Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredientformulations that contain tolperisone | |
| AR065297A1 (es) | Formulaciones biodisponibles de compuestos heterociclicos | |
| JP2023529612A5 (https=) | ||
| RU2006113550A (ru) | Циклогексильные производные, замещенные аминоалкиламидами | |
| CA2870240A1 (en) | Analgesic | |
| JP2004525178A5 (https=) | ||
| CN1168134A (zh) | 用于生产左旋丁哌卡因以及相关的哌啶甲酰苯胺麻醉剂的外消旋化方法 | |
| RU2010154417A (ru) | Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств | |
| EP0068998A1 (fr) | Aryl-1 aminométhyl-2 cyclopropanes carboxylates (Z), leur préparation et leur application en tant que médicaments utiles dans le traitement d'algies diverses | |
| DE60216239T8 (de) | Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie | |
| ATE289583T1 (de) | Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen | |
| RU2004129767A (ru) | Хинолиновые производные | |
| JP2025506844A5 (https=) | ||
| DK1224161T3 (da) | Nitroxyderivater af (R)- og (S)-carnitin | |
| CN103930105B (zh) | 2-(n,n-二甲基氨基)-丙酸十二烷基酯的活性对映体 | |
| KR900011759A (ko) | 사이클로 헥산아세트 아미드 유도체 |